JAZZ - Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q2 2021 Results - Earnings Call Transcript

Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Conference Call August 03, 2021 4:30 PM ET Company Participants Andrea Flynn – Investor Relations Bruce Cozadd – Chairman and Chief Executive Officer Renee Gala – Executive Vice President and Chief Financial Officer Dan Swisher – President Rob Iannone – Executive Vice President-R&D and Chief Medical Officer Conference Call Participants Ken Cacciatore – Cowen and Company Jessica Fye – JPMorgan Jason Gerberry – Bank of America Melina Santoro – Morgan Stanley David Amsellem – Piper Sandler Gary Nachman – BMO Capital Markets Annabel Samimy – Stifel Esther Rajavelu – UBS Marc Goodman – SVB Leerink Graig Suvannavejh – Goldman Sachs David Steinberg – Jefferies Balaji Prasad – Barclays Presentation Operator Good day and thank you for standing-by. Welcome to the Second Quarter 2021 Jazz Pharmaceuticals Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would

For further details see:

Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q2 2021 Results - Earnings Call Transcript